跳至主要内容
临床试验/NL-OMON50944
NL-OMON50944已完成4 期

EXtended use of FOsfomycin for the treatment of CYstitis in primary care - EXFOCY

niversitair Medisch Centrum Utrecht0 个研究点目标入组 777 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
777

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • -Adult women (><=18 years of age) with a diagnosis of uncomplicated cystitis in
  • primary care
  • - Cystitis diagnosis is according to the flow diagram in the Dutch
  • NHG-guideline. In line with the NHG guideline 2020, recognition of symptoms
  • should always be accompanied with either a positive nitrite test or leucocyte
  • and dipslide test

排除标准

  • -Pregnancy or nursing
  • -Diabetes Mellitus
  • -Immunocompromised state
  • o Untreated infection with human immunodeficiency virus (hiv)
  • o Use of high-dose systemic corticosteroids
  • o Use of other immunosuppressive medication (specified in protocol)
  • -Presence of an indwelling urinary catheter
  • -History of abnormalities in urinary tract or kidneys
  • -Neurogenic bladder dysfunction
  • -UTI in past 28 days before inclusion
  • -Antibiotic prophylaxis in past 28 days with nitrofurantoin or fosfomycin
  • -Known GFR <30mL/min
  • -Contra-indication for nitrofurantoin or fosfomycin use (e.g. allergic
  • reactions, lung or liver reaction or peripheral neuropathy after previous use
  • in clinical history, acute porphyria, G6PD deficiency)
  • -Current use of an antibiotic for any reason

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验